Baci-rx en es it fr

Baci-rx Brand names, Baci-rx Analogs

Baci-rx Brand Names Mixture

  • No information avaliable

Baci-rx Chemical_Formula


Baci-rx RX_link

Baci-rx fda sheet

Baci-rx msds (material safety sheet)

Baci-rx MSDS

Baci-rx Synthesis Reference

No information avaliable

Baci-rx Molecular Weight

1422.69 g/mol

Baci-rx Melting Point

221 - 225 oC

Baci-rx H2O Solubility

Freely soluble

Baci-rx State


Baci-rx LogP


Baci-rx Dosage Forms

Drug premix; Ointment; Powder; Powder for solution

Baci-rx Indication

For the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug. Also used in ointment form for topical treatment of a variety of localized skin and eye infections, as well as for the prevention of wound infections.

Baci-rx Pharmacology

Bacitracin is a mixture of related cyclic polypeptides produced by organisms of the licheniformis group of Bacillus subtilis var Tracy. As a polypeptide, toxic, and difficult to use chemical, Bacitracin doesn't work well orally, however is very effective topically. Bacitracin exerts pronounced antibacterial action in vitro against a variety of gram-positive and a few gram-negative organisms. However, among systemic diseases, only staphylococcal infections qualify for consideration of bacitracin therapy.

Baci-rx Absorption

Absorption of bacitracin following intramuscular injection is rapid and complete. Absorption from the gastrointestinal tract following oral administration is not appreciable. Absorption following topical application is negligible.

Baci-rx side effects and Toxicity

Oral, mouse: LD50 = >3750 mg/kg.

Baci-rx Patient Information

Baci-rx Organisms Affected

Enteric bacteria and other eubacteria